For the first time ever, scientists have been able to visualize the germinated active cells of a commercial Bacillus-based probiotic inside the gut of birds. Adisseo, an expert in animal sciences, and Novozymes, a leader in biological solutions, revealed at a press conference in Paris on March 5th that as a first for the industry they have been able to demonstrate and visualize in detail the germination of their Alterion? technology.
During the gathering, the partnership presented novel data and innovative techniques to scientifically prove that their probiotic is an effective and consistent solution for poultry.
“For the first time ever, scientists have been able to visualize the germinated active cells of a commercial Bacillus-based probiotic inside the gut of birds. The process, known as germination, is crucial to demonstrate the desired benefits of probiotics for animal
production,” explained Damien Prévéraud, Global Technical and Scientific Manager Health by Nutrition at Adisseo. “These include improved health, growth, resilience and feed utilization; which in turn offer a natural alternative to antibiotic growth promoters.”
Adisseo and Novozymes’ joint Bacillus probiotic, Alterion, is a unique, proprietary strain – carefully selected through rigorous screening and developed specifically for improvements of poultry performance across the world.